Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance

Area of Science:

• Cellular Biology
• Metabolic Diseases
• Molecular Mechanisms

Background:

• Autophagy is a fundamental cellular process for degrading damaged components.
• Obesity is linked to impaired cellular functions, including autophagy.
• Defective autophagy may contribute to metabolic dysfunction in obesity.

Purpose of the Study:

• To investigate the role of autophagy, particularly Atg7, in obesity-related metabolic dysfunction.
• To determine if restoring autophagy can ameliorate insulin resistance and ER stress in obese models.

Main Methods:

• Utilized genetic and dietary models of obesity.
• Manipulated Atg7 expression in liver cells (in vitro) and in vivo.
• Assessed insulin signaling, ER stress markers, and glucose tolerance.

Main Results:

• Obese models showed significantly reduced autophagy and Atg7 expression in the liver.
• Suppression of Atg7 led to defective insulin signaling and increased ER stress.
• Restoring Atg7 in obese mice improved insulin action, reduced ER stress, and enhanced glucose tolerance.
• The benefits of Atg7 restoration were dependent on downstream autophagy mediator Atg5.

Conclusions:

• Autophagy, regulated by Atg7, is crucial for maintaining organelle function and insulin signaling.
• Loss of autophagy is a key factor in the defective insulin action observed in obesity.
• Targeting autophagy represents a potential therapeutic strategy for metabolic disorders like obesity.